Assignee
HUIDAGENE THERAPEUTICS SINGAPORE PTE LTD
SG·1 granted patent·7 pending applications·0 citations·filing 2022–2024
Top patents by PatentIndex Score
8 records- 0159US2025207115A1Engineered crispr-cas13f system and uses thereofHUIDAGENE THERAPEUTICS SINGAPORE PTE LTD·Filed 2023·Application pending·0 cites
- 0258US2025205366A1Guide nucleic acid targeting mecp2 and uses thereofHUIDAGENE THERAPEUTICS SINGAPORE PTE LTD·Filed 2023·Application pending·0 cites
- 0357US12454690B2Type VI-E and type VI-F CRISPR-Cas system and uses thereofHUIDAGENE THERAPEUTICS SINGAPORE PTE LTD·Filed 2022·Granted Oct 28, 2025·0 cites·26 claims
- 0457US2025270529A1Engineered crispr-cas13f system and uses thereofHUIDAGENE THERAPEUTICS SINGAPORE PTE LTD·Filed 2022·Application pending·0 cites
- 0555US2024368629A1Rna adeno-associated virus (raav) vector and uses thereofHUIDAGENE THERAPEUTICS SINGAPORE PTE LTD·Filed 2024·Application pending·0 cites
- 0650US2025283063A1Novel crispr-cas12i systems and uses thereofHUIDAGENE THERAPEUTICS SINGAPORE PTE LTD·Filed 2023·Application pending·0 cites
- 0749US2025101394A1Novel crispr-cas12i systems and uses thereofHUIDAGENE THERAPEUTICS SINGAPORE PTE LTD·Filed 2023·Application pending·0 cites
- 0842US2025304940A1Programmable adenine base editor and uses thereofHUIDAGENE THERAPEUTICS SINGAPORE PTE LTD·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HUIDAGENE THERAPEUTICS SINGAPORE PTE LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →